Europe Syphilis Testing Market Size, Share & Industry Trends Analysis Report By Type, By Location of Testing testing), By Country and Growth Forecast, 2022 - 2028

The Europe Syphilis Testing Market is expected to witness market growth of 5.2% CAGR during the forecast period (2022-2028).

The patient may get a rash that starts on the trunk and spreads to the entire body, including the palms of hands and the soles of feet, within a few weeks of the original chancre curing. This rash is usually not irritating, although it may be accompanied by warty ulcers in the mouth or genital area. Hair loss, muscle aches, a fever, a sore throat, and enlarged lymph nodes are additional common side effects. These signs and symptoms could fade away in a few weeks or reappear several times over a year.

Through the placenta or at delivery, syphilis can contaminate babies delivered to syphilis-positive mothers. Deafness, tooth abnormalities, and a saddle nose are some of the later indications and symptoms. Babies born with syphilis, on the other hand, can be born prematurely or die in the womb before birth, or die after birth.

In this region, HIV/AIDS protection, medication, and care have become increasingly important in recent decades. More than two million people are affected by the disease in the WHO European Region, where no country has been spared. Even though this figure is low in comparison to the worst-affected region, it represents an extraordinary increase in new cases. One of the region's most significant public health challenges is the rapid spread of HIV throughout Eastern Europe. In the previous ten years, three eastern European countries have gone from a few recorded cases to an estimated HIV prevalence of more than 1% among persons aged 15-49.

The Germany market dominated the Europe Syphilis Testing Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $96.7 million by 2028. The UK market is poised to grow at a CAGR of 4.4% during (2022 - 2028). Additionally, The France market is expected to display a CAGR of 6% during (2022 - 2028).

Based on Type, the market is segmented into Primary & Secondary Syphilis and Others. Based on Location of Testing, the market is segmented into Laboratory testing and Point of care (POC) testing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG, Abbott Laboratories, DiaSorin S.p.A. (Luminex Corporation), Hologic, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher Corporation (Cepheid), and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Primary & Secondary Syphilis
• Others

By Location of Testing

• Laboratory testing
• Point of care (POC) testing

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Siemens Healthineers AG
• Abbott Laboratories
• DiaSorin S.p.A. (Luminex Corporation)
• Hologic, Inc.
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• Becton, Dickinson and Company
• Danaher Corporation (Cepheid)
• F. Hoffmann-La Roche Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free